'

Establishment of the National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group (CTRad) Biomarker Support Network

'

Launched in 2009, the National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group (CTRad) was established to reinvigorate clinical and translational research relating to radiotherapy and radiobiology in the UK. The group has a broad remit with the overarching dual aims of developing a portfolio of practice-changing trials and actively promoting the translation of new discoveries into practice. …

Read More

'

Proton beam therapy (PBT) clinical research discussion meeting

'

The forthcoming introduction of proton beam therapy (PBT) is an important national investment for the UK, and we aspire to become world leaders in PBT. As well as planning the clinical service, it will be essential to have a well coordinated research agenda that can make the very best use of this new technology for patients. …

Read More

'

Funding of children’s cancer research: 2008 data from the ICRP portfolio

'

In response to a request from the UK children’s cancer community for help in benchmarking UK activity against work elsewhere, NCRI has undertaken an analysis of the ICRP database to look at the nature and volume of childhood cancer research funded by NCRI Partners in the UK compared with other countries participating in ICRP data‐sharing. …

Read More

'

Radiotherapy physics research in the UK: challenges and proposed solutions

'

In 2011, the Clinical and Translational Radiotherapy Research Working Group (CTRad) of the National Cancer Research Institute brought together UK radiotherapy physics leaders for a think tank meeting. Following a format that CTRad had previously and successfully used with clinical oncologists, 23 departments were asked to complete a pre-meeting evaluation of their radiotherapy physics research infrastructure and the strengths, weaknesses, opportunities and threats within their own centre.…

Read More